- AlphaTON will build a US$100M TON treasury through validation and project development.
- Funding comes from a securities placement and a BitGo loan.
- The announcement caused stock volatility, while biotech research continues.
- Leadership includes Brittany Kaiser, Enzo Villani, and key crypto advisors.
Portage Biotech has rebranded as AlphaTON Capital Corp., shifting its corporate strategy towards building a Toncoin (TON) treasury worth approximately US$100 million (AU$152.7 million). Trading on Nasdaq will continue under its existing symbol until 4 September, when the ticker will switch from PRTG to ATON.
The company said its mission is to accumulate TON tokens, secure the network through validation and staking, and develop new projects in Telegram’s blockchain-integrated environment. This positions AlphaTON as a digital asset treasury distinct from others by focusing not just on asset holding but also on fostering DeFi, gaming, and business applications linked to Telegram.
Brittany Kaiser, newly appointed CEO and board member, said the integration of TON with Telegram places the blockchain at the start of a powerful growth phase and creates what she views as the clearest route to mainstream adoption of decentralised technology. She emphasised that the shift towards user-driven platforms is both inevitable and essential, positioning AlphaTON shareholders at the forefront of this transition.
With Telegram’s billion-user ecosystem and TON’s robust blockchain architecture, we are investing in a future where users own their data and digital assets, developers innovate without barriers, and financial inclusion becomes a global reality.
Brittany Kaiser, CEO of AlphaTONThe leadership team adds Enzo Villani as Executive Chairman and CIO, alongside advisors Anthony Scaramucci, Michael Terpin, and Jaime Rogozinski.
Related: TON’s Golden Visa Claims Debunked by UAE as Token Price Slips
Funding and Market Response
AlphaTON will fund its TON acquisition through a securities placement worth about US$38 million (AU$58.1 million) alongside a US$35 million (AU$53.4 million) loan provided by BitGo. Kaiser confirmed the treasury’s initial value would surpass US$100 million (AU$152.7 million) despite the outlay being less than US$70 million (AU$106.9 million), due to discounted acquisitions and TON contributions.
The rebrand announcement triggered share price swings, with stock climbing to US$9.43 (AU$14.4) before settling at US$6.84 (AU$10.5). While pivoting to digital assets, AlphaTON confirmed it will still progress its biotech research programmes.
Related: Crypto Giants Target Australia’s $4.3T Pension System as Next Growth Frontier
Credit: Source link
